Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LJEVac Lot Consistency and Non-inferiority in Bangladeshi Infants
NCT01567865Phase 4Completed
- Sponsor
- PATH
- Start
- May 2012
- Primary completion
- Dec 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of japanese encephalitis vaccine sa14-14-2 in Japanese encephalitis (JE), sponsored by PATH. Started May 2012; status: completed.
02
Drugs
japanese encephalitis vaccine sa14-14-2
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT01567865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01567865.